New Delhi, July 24 -- Pharma stocks traded lower on Friday, 24 July, after US President Donald Trump unveiled a phased tariff plan on imported generic medicines, raising concerns over the outlook for Indian drug exporters.

Abbott India shares were the biggest laggards, falling 3.69% on the BSE. Akums Drugs & Pharmaceuticals shares also witnessed notable selling pressure, slipping 2.06%, while Acutaas Chemicals shares declined 1.99%, and Aarti Drugs shares fell 1.76%. Shares of Alembic dropped 1.61%, Ajanta Pharma lost 1.43%, and Artemis Medicare Services declined 1.32%, reflecting weakness across the broader pharma pack.

Under the proposed policy, generic drugs imported into the US will continue to attract zero tariffs for two years fro...